Gentherm posts record Q2 revenue, triples buyback, reaffirms Modine deal

Plus: Intermountain Health cuts 93 roles closing clinics in Colorado and Montana. The day's rules, money, and enforcement, sourced and tiered below.

Share

Plus: Intermountain Health cuts 93 roles closing clinics in Colorado and Montana. The day's rules, money, and enforcement, sourced and tiered below.

American Health Intel
Rules · Money · Medicine · Decoded daily
The Ledger Saturday, July 25, 2026
Gentherm posts record Q2 revenue, triples buyback, reaffirms Modine deal
Plus: Intermountain Health cuts 93 roles closing clinics in Colorado and Montana. The day's rules, money, and enforcement, sourced and tiered below.
Earnings  Confidence: High
Gentherm, the automotive and medical device maker behind seat heating and the non-opioid ThermaZone pain-therapy device, posted record quarterly revenue and nearly tripled its stock buyback to $400 million.
Q2 revenue hit $416.2M, up 11%. Gentherm raised FY26 guidance and reaffirmed its roughly $1 billion Reverse Morris Trust combination with Modine's Performance Technologies unit, on track to close early Q4.
Why it matters
This is a routine earnings beat with a bigger stock buyback, not something most patients will notice directly, but it points to steady demand in the medical device supply chain.
Other  Confidence: Medium
Intermountain Health, the Salt Lake City nonprofit hospital system, is closing clinics across Colorado and Montana this week and cutting about 93 leadership and staff jobs, citing long-term financial pressure.
Colorado loses two occupational health clinics and a sports-medicine clinic; Montana loses a Lewistown family-medicine clinic. Bariatric surgery stays. Changes took effect July 24. Severance offered where applicable.
Why it matters
If you're a patient at one of the closed clinics, you'll need to find a new care location; the cuts show even a large nonprofit system tightening its footprint.
Also today
UHealth and UnitedHealthcare still without a deal, 6 days to deadline Read
Samsung Biologics pays $1.81B for GLP-1 peptide manufacturer PolyPeptide Read
FRONTIER SCAN: Healthcare ransomware attacks rose 14% in H1 2026 Read
249
Records
$17.6B
Enforcement
10
Deadlines
80
Rules
Read this issue + the trackers
Pick your field on the site and every story tells you what it means for you.
Reply to this email and tell us what you want covered. We read everything.
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe